NCT07374107 MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
| NCT ID | NCT07374107 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Myositis International Health & Research Collaborative Alliance Foundation |
| Condition | IBM |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2025-06-25 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2025-06-25 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly online) methods of open-ended questions, community forums and survey to identify the most pressing research concerns as identified by patients. Findings will be analyzed to create a patient-voiced set of research priorities that can guide the direction of research and help inform funding decisions across myositis diseases. Potential participants can express interest via https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/
Eligibility Criteria
Inclusion Criteria: * Ability to provide informed consent * Have a clinician diagnosis of an idiopathic inflammatory myopathy or be a care partner or parent of a person living with an idiopathic inflammatory myopathy. * Participants who may have signed up through the MIHRA Patient Contact Registry https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/ Exclusion Criteria: * Under the age of 7 years old * Do not have a diagnosis of an inflammatory myopathy
Contact & Investigator
Lesley Ann Saketkoo, MD, MPH
STUDY CHAIR
MIHRA Foundation
Frequently Asked Questions
Who can join the NCT07374107 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, studying IBM. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07374107 currently recruiting?
Yes, NCT07374107 is actively recruiting participants. Contact the research team at info@MiHRAfoundation.org for enrollment information.
Where is the NCT07374107 trial being conducted?
This trial is being conducted at New Orleans, United States.
Who is sponsoring the NCT07374107 clinical trial?
NCT07374107 is sponsored by Myositis International Health & Research Collaborative Alliance Foundation. The principal investigator is Lesley Ann Saketkoo, MD, MPH at MIHRA Foundation. The trial plans to enroll 700 participants.